MULTIPLE SCLEROSIS
![Foto de MULTIPLE SCLEROSIS](/img/grupo.png)
![Foto de Hospital Nacional de Parapléjicos](/img/noimage_org.png)
Hospital Nacional de Parapléjicos
Toledo, EspañaPublications in collaboration with researchers from Hospital Nacional de Parapléjicos (2)
2023
-
Early biochemical analysis of COVID-19 patients helps severity prediction
PLoS ONE, Vol. 18, Núm. 5 May
2022
-
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
Journal of Neuroinflammation, Vol. 19, Núm. 1